Pharma
Treviamet (Sitagliptin + Metformin HCl Tablets)
Combination DPP-4 inhibitor and Biguanide; 50 mg/850 mg Sitagliptin/Metformin tablets for Type 2 Diabetes.
Treviamet (Sitagliptin + Metformin HCl Tablets)
Treviamet is a combination oral antidiabetic medication containing Sitagliptin and Metformin Hydrochloride. Sitagliptin is a DPP-4 inhibitor that works by increasing levels of natural substances called incretins, which help control blood sugar by increasing insulin release and decreasing the amount of sugar made by the liver. Metformin is a biguanide that helps lower blood sugar by reducing the amount of glucose produced by the liver and improving insulin sensitivity. This combination is indicated to improve glycemic control in adults with type 2 diabetes mellitus. It is not intended for type 1 diabetes or diabetic ketoacidosis. Common side effects may include diarrhea, nausea, and headache.
You May Also Like
Combination DPP-4 inhibitor and Biguanide; 50 mg/500 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50 mg/1000 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50mg/500mg Vildagliptin/Metformin tablets for Type 2 Diabetes control.
Triple antidiabetic combo; Dapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin ER 1000 mg (28 tablets) for Type 2 Diabetes.